MétaCan
Menu
Back to cohort
Record W2080370558 · doi:10.1038/bjc.2014.567

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study

2014· article· en· W2080370558 on OpenAlexafffund
Martin Köbel, Jason Madore, Susan J. Ramus, Blaise Clarke, Paul D.P. Pharoah, Suha Deen, David D.L. Bowtell, Kunle Odunsi, Usha Menon, Quaid Morris, Shashikant Lele, Wiam Bshara, Lara Sucheston, Matthias W. Beckmann, Alexander Hein, Falk C. Thiel, Arndt Hartmann, David L. Wachter, Michael S. Anglesio, Estrid Høgdall, Allan Jensen, Claus Høgdall, Kimberly R. Kalli, Brooke L. Fridley, Gary L. Keeney, Zachary C. Fogarty, Robert A. Vierkant, S. Liu, Sun Young Cho, Gregg Nelson, Praful Ghatage, Aleksandra Gentry‐Maharaj, Simon A. Gayther, Elizabeth Benjamin, Martin Widschwendter, Maria P. Intermaggio, Barry P. Rosen, Marcus Q. Bernardini, Helen Mackay, Amit M. Oza, Patricia Shaw, Mercedes Jimenez‐Liñan, K E Driver, Jennifer Alsop, Marie Mack, Jennifer M. Koziak, Helen Steed, Carol A. Ewanowich, Anna DeFazio, Georgia Chenevix‐Trench, Sián Fereday, Bo Gao, Sharon E. Johnatty, Joshy George, Laura Galletta, Ellen L. Goode, Susanne K. Kjær, David G. Huntsman, Peter A. Fasching, Kirsten B. Moysich, James D. Brenton, Linda E. Kelemen

Bibliographic record

VenueBritish Journal of Cancer · 2014
Typearticle
Languageen
FieldMedicine
TopicFolate and B Vitamins Research
Canadian institutionsRoyal Alexandra HospitalAlberta Health ServicesUniversity of British ColumbiaUniversity of TorontoCalgary Laboratory ServicesPrincess Margaret Cancer CentreBC Cancer AgencyFoothills Medical CentreUniversity of Calgary
FundersCancer Council South AustraliaMedical Research CouncilCanadian Institutes of Health ResearchNational Institute for Health and Care ResearchFred C. and Katherine B. Andersen FoundationNational Cancer InstituteUniversity College LondonCancer Council VictoriaCalgary Laboratory ServicesMayo Foundation for Medical Education and ResearchCancer Council TasmaniaNational Institutes of HealthCancer Council NSWNational Health and Medical Research CouncilCancer Research UKUniversity of SydneyNIHR Cambridge Biomedical Research CentreU.S. Department of Defense
KeywordsOvarian carcinomaOvarian cancerSurvival analysisOncologyMedicineOvarian carcinomasCarcinomaOvarian tissueOvaryPathologyGynecologyInternal medicineBiologyCancer

Abstract

fetched live from OpenAlex

BACKGROUND: Folate receptor 1 (FOLR1) is expressed in the majority of ovarian carcinomas (OvCa), making it an attractive target for therapy. However, clinical trials testing anti-FOLR1 therapies in OvCa show mixed results and require better understanding of the prognostic relevance of FOLR1 expression. We conducted a large study evaluating FOLR1 expression with survival in different histological types of OvCa. METHODS: Tissue microarrays composed of tumour samples from 2801 patients in the Ovarian Tumour Tissue Analysis (OTTA) consortium were assessed for FOLR1 expression by centralised immunohistochemistry. We estimated associations for overall (OS) and progression-free (PFS) survival using adjusted Cox regression models. High-grade serous ovarian carcinomas (HGSC) from The Cancer Genome Atlas (TCGA) were evaluated independently for association between FOLR1 mRNA upregulation and survival. RESULTS: FOLR1 expression ranged from 76% in HGSC to 11% in mucinous carcinomas in OTTA. For HGSC, the association between FOLR1 expression and OS changed significantly during the years following diagnosis in OTTA (Pinteraction=0.01, N=1422) and TCGA (Pinteraction=0.01, N=485). In OTTA, particularly for FIGO stage I/II tumours, patients with FOLR1-positive HGSC showed increased OS during the first 2 years only (hazard ratio=0.44, 95% confidence interval=0.20-0.96) and patients with FOLR1-positive clear cell carcinomas (CCC) showed decreased PFS independent of follow-up time (HR=1.89, 95% CI=1.10-3.25, N=259). In TCGA, FOLR1 mRNA upregulation in HGSC was also associated with increased OS during the first 2 years following diagnosis irrespective of tumour stage (HR: 0.48, 95% CI: 0.25-0.94). CONCLUSIONS: FOLR1-positive HGSC tumours were associated with an increased OS in the first 2 years following diagnosis. Patients with FOLR1-negative, poor prognosis HGSC would be unlikely to benefit from anti-FOLR1 therapies. In contrast, a decreased PFS interval was observed for FOLR1-positive CCC. The clinical efficacy of FOLR1-targeted interventions should therefore be evaluated according to histology, stage and time following diagnosis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.013
metaresearch head score (Gemma)0.017
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.013
Threshold uncertainty score0.071

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0130.017
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.002
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.146
GPT teacher head0.449
Teacher spread0.302 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations110
Published2014
Admission routes2
Has abstractyes

Explore more

Same venueBritish Journal of CancerSame topicFolate and B Vitamins ResearchFrench-language works237,207